2-(2-hydroxyethylsulfanyl)-3-methyl-1,4-naphthoquinone has been researched along with Vitreoretinopathy, Proliferative in 1 studies
Vitreoretinopathy, Proliferative: Vitreoretinal membrane shrinkage or contraction secondary to the proliferation of primarily retinal pigment epithelial cells and glial cells, particularly fibrous astrocytes, followed by membrane formation. The formation of fibrillar collagen and cellular proliferation appear to be the basis for the contractile properties of the epiretinal and vitreous membranes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Three new N(1)-alkylcarbonyl-5-fluorouracil derivatives that are prodrugs of 5-fluorouracil (FU), one of them being a co-drug FU-retinoic acid (RA), were studied as potentially effective drugs against postsurgical proliferative vitreoretinopathy (PVR)." | 7.72 | Fluorouracil prodrugs for the treatment of proliferative vitreoretinopathy: formulation in silicone oil and in vitro release of fluorouracil. ( Jolimaître, P; Malet-Martino, M; Martino, R, 2003) |
| "Three new N(1)-alkylcarbonyl-5-fluorouracil derivatives that are prodrugs of 5-fluorouracil (FU), one of them being a co-drug FU-retinoic acid (RA), were studied as potentially effective drugs against postsurgical proliferative vitreoretinopathy (PVR)." | 3.72 | Fluorouracil prodrugs for the treatment of proliferative vitreoretinopathy: formulation in silicone oil and in vitro release of fluorouracil. ( Jolimaître, P; Malet-Martino, M; Martino, R, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jolimaître, P | 1 |
| Malet-Martino, M | 1 |
| Martino, R | 1 |
1 other study available for 2-(2-hydroxyethylsulfanyl)-3-methyl-1,4-naphthoquinone and Vitreoretinopathy, Proliferative
| Article | Year |
|---|---|
Fluorouracil prodrugs for the treatment of proliferative vitreoretinopathy: formulation in silicone oil and in vitro release of fluorouracil.
Topics: Chemistry, Pharmaceutical; Drug Stability; Fluorouracil; Kinetics; Magnetic Resonance Spectroscopy; | 2003 |